PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
09/07/26	NT$12.00	-0.83%	287,577
08/07/26	NT$12.10	-2.02%	248,539
07/07/26	NT$12.35	-1.20%	262,733
06/07/26	NT$12.50	+1.21%	500,399

End-of-day quote Taiwan S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Taiwan S.E. Other stock markets 09/07/2026			5-day change	1st Jan Change
12.00 ^TWD	-0.83%		-2.83%	-11.11%

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	2.38B 74.26M 64.96M 59.91M 55.34M 105M 7.08B 107M 716M 281M 3.49B 279M 273M 11.99B	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	1.33B 41.58M 36.37M 33.54M 30.98M 58.79M 3.97B 59.78M 401M 157M 1.95B 156M 153M 6.72B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.64%	Yield 2024 *	-	Yield 2025	-

06-03	PhytoHealth's Revenue Rises 18% in May	MT
05-11	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/09/25	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
13/08/25	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
06/05/25	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
05/05/25	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
04/05/25	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
27/02/25	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
11/11/24	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

09/08/22	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
05/07/22	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
24/05/22	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
08/04/22	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
09/03/22	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Stock

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation: PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news : PhytoHealth Corporation

Press Releases: PhytoHealth Corporation

Quotes and Performance

Course Extremes

Managers and Directors: PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-0.83%
1 week	-2.83%
Current month	-0.83%
1 month	-2.44%
3 months	-4.38%
6 months	-13.04%
Current year	-11.11%

1 week	11.95	12.7
1 month	11.8	12.9
Current year	11.4	15.25
1 year	11.4	17.9
3 years	11	24.3
5 years	11	25.25
10 years	10.25	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	13/06/2017
Chih Yuan Huang DFI	Director of Finance/CFO	-	11/05/2021
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	30/07/2021

Director	Title	Age	Since
Ching Chung Tsai BRD	Director/Board Member	-	12/06/2014
Yue Ju Lai BRD	Director/Board Member	-	16/03/2010
Yi Li Lee CHM	Chairman	55	26/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	-0.83%	-2.83%	-8.40%	-48.39%	74.26M
REGENERON PHARMACEUTICALS, INC.	-0.51%	+1.57%	+17.05%	-7.50%	67.61B
UCB	-5.16%	-8.63%	+38.70%	+202.12%	51.6B
SAMSUNG BIOLOGICS CO.,LTD.	+5.28%	+39.50%	+39.50%	+39.50%	43B
CSL LIMITED	-0.96%	-2.21%	-49.71%	-54.06%	40.94B
BIOGEN INC.	+0.12%	-7.85%	+48.39%	-28.27%	29.4B
MODERNA, INC.	-10.83%	-14.41%	+102.94%	-45.78%	27.09B
INCYTE CORPORATION	-1.53%	-0.13%	+70.16%	+86.29%	23.32B
INNOVENT BIOLOGICS, INC.	-1.28%	-2.21%	+7.93%	+170.64%	19.92B
SWEDISH ORPHAN BIOVITRUM AB	-1.59%	-1.63%	+64.87%	+130.98%	16.91B
Average	-1.75%	-3.16%	+33.14%	+44.55%	31.99B
Weighted average by Cap.	-1.56%	-2.95%	+30.99%	+46.76%

	2024	2025
Net sales	154M 4.78M 4.19M 3.86M 3.57M 6.77M 456M 6.88M 46.12M 18.11M 225M 17.96M 17.57M 773M	135M 4.19M 3.67M 3.38M 3.12M 5.93M 400M 6.03M 40.42M 15.87M 197M 15.74M 15.4M 677M
Net income	-73.5M -2.29M -2M -1.85M -1.71M -3.24M -218M -3.29M -22.08M -8.67M -108M -8.6M -8.41M -370M	-58.2M -1.81M -1.59M -1.46M -1.35M -2.56M -173M -2.61M -17.48M -6.86M -85.2M -6.81M -6.66M -293M
Net Debt	-1.06B -33.09M -28.94M -26.69M -24.65M -46.78M -3.16B -47.57M -319M -125M -1.55B -124M -122M -5.34B	-1.05B -32.68M -28.59M -26.37M -24.35M -46.21M -3.12B -46.99M -315M -124M -1.54B -123M -120M -5.28B